Vitaae Review - Does It Really Work?

Welcome to our Vitaae review. Vitaae is marketed as a supplement for overall brain health and effectiveness, yet a thorough review suggests there may be gaps in its effectiveness. Its formula, while unique, invites questions. Is it the breakthrough it's marketed as, or does a closer look reveal a different story?

In our Vitaae review, we put this nootropic supplement to the test and carefully examine precisely where its ingredient lineup might not live up to expectations.

We're here to uncover the facts about Vitaae. We'll analyze the ingredients, investigate any potential interactions and side effects, and assess its real impact as a brain-enhancing supplement.

SANE's Claimed Benefits of Vitaae

SANE claims that Vitaae offers the following:

Alongside these bold and somewhat hard-to-believe claims, the company also makes a number of spurious claims about the products effectiveness. The citation for which is a limited article on one of the ingredients, Citicholine, which is simply not a relevant article to reference, not least because the dosages used in the study are not remotely comparable.

We therefore have to question the company's honesty and ethics, both in how they market the product and in how they choose to misrepresent evidence for the big bold claims they make to sell the product.

Our Experience With Vitaae

When we began experimenting with Vitaae, we hoped its potential would match its performance. However, our experience turned out to be quite plain. Despite Vitaae's array of promised benefits, from clearing brain fog to enhancing energy, mood, and mental clarity, the outcomes didn’t quite hit the mark.

The product claims to combat brain fog and support sharp thinking. Even though it contains Citicoline, known for cognitive benefits, the dose of 100mg might not be strong enough to see a real difference [1, 2]. This lower dosage might explain why we didn’t see the improvements we hoped for.

Vitaae also includes Acetyl L-Carnitine and Omega-3 fatty acids, recognized for cognitive enhancements [5, 6]. But without clear information on how much of these are in the mix, it's hard to say if they could be effective.

For mood improvements, it relies on Vitamin D and Magnafolate C, which have roles in mood regulation [7, 8]. Yet, any mood boosts were subtle, potentially varying from person to person [9].

Coenzyme Q10 is another ingredient, known for its antioxidant qualities and possible brain health benefits [10]. However, at 50mg, its amount may be too low for tangible benefits. And those remarkable effects on memory or a surge in youthful vitality? They remained out of reach.

Vitaae mirrors a familiar pattern in the supplement sector—a product that's heavily promoted but doesn’t fully deliver. Its main issue seems to be the ingredient amounts, with some effective nootropic elements absent, likely cut to reduce costs, affecting its overall effectiveness.

It highlights a lesson: a supplement might look good at first glance, but a closer look often reveals gaps between promises and actual benefits.

Research And Evidence

Misleading Claims

While Vitaae and its parent company, SANE Laboratories, prominently cite the McGlade et al. (2012) study to support their product's cognitive-enhancing claims, a more rigorous scrutiny raises substantial doubts about this interpretation and the company's marketing practices.

To start, a fundamental discrepancy lies in the dosage of Citicoline used in the study compared to the dosage found in Vitaae. The research employed a daily dosage of 250mg and 500mg of Citicoline, while Vitaae includes a significantly smaller amount of just 100mg per serving. The lower dosage might not provide the same cognitive benefits observed in the study, meaning the company's claims, based on this study, are misleading. This discrepancy is a matter of critical concern and puts into question the honesty of the marketing efforts.

It's also worth noting that the study’s positive results were specific to a population of healthy adult women. Generalizing these results to all users — men, women of different age groups, and individuals with varying health statuses — is scientifically unsound.

Vitaae's marketing materials heavily lean on this one study, portraying it as definitive proof of their product's effectiveness. However, drawing definitive conclusions from a single study and failing to consider dosage differences is misleading and overstates the product's potential benefits.

The company is cherry-picking data and simplifying complex scientific research to make its product appear more effective than it actually is. This practice is not just scientifically questionable, but also raises ethical concerns about transparency and honesty in their marketing strategies.

A responsible company should convey the realities of scientific research accurately, including the limitations of a study and potential differences in individual responses. Therefore, potential users should approach Vitaae and the claims made by SANE Laboratories with a high degree of skepticism.

Here is a detailed list of potential side effects you might encounter with Vitaae:

Main problems experienced with Vitaae 

1. Gastrointestinal Issues: Both Vitamin D and Omega-3 Fatty Acid Concentrate have been reported to cause gastrointestinal disturbances, such as nausea, bloating, or diarrhea (14,15).
2. Fishy Aftertaste: Some users may experience a fishy aftertaste or odor due to the Omega-3 Fatty Acid Concentrate sourced from fish oil (16).
3. Hypervitaminosis D: While less common, excessive intake of Vitamin D may lead to hypervitaminosis D, marked by hypercalcemia, nausea, vomiting, weakness, and frequent urination (17).
4. Blood Thinning: Omega-3 fatty acids, while beneficial for heart health, can have anticoagulant effects. This might lead to bleeding problems, particularly if you're also taking blood-thinning medications (18).
5. Lower Blood Pressure: Omega-3 fatty acids may also lower blood pressure. While generally beneficial, this could cause issues for those with already low blood pressure or taking antihypertensive drugs (19).
6. Restlessness and Insomnia: Acetyl L-Carnitine might cause restlessness and sleep disturbances in some individuals (20).
7. Allergic Reactions: Rarely, some individuals may experience allergic reactions to ingredients like Gymnema Sylvestre Leaf Extract (21).
8. Drug Interactions: Certain components, like Acetyl L-Carnitine and Coenzyme Q10, might interact with specific medications, altering their effects (22,23).

Most side effects are likely to be mild and most users can reasonably expect not to experience any significant issues.

NooCube offers a distinct advantage over Vitaae due to its transparent ingredient profile and careful selection of scientifically-supported nootropics.

Vitaae by SANE Laboratories doesn't quite hit the mark because of its vague dosages and a proprietary blend that keeps the exact amounts of ingredients under wraps. This opacity makes it hard for people to know what they're taking and if it could work (27). Also, the way the company promotes Vitaae, using studies that seem to support their claims without showing the whole picture, brings up concerns about their commitment to solid science (28).

By way of contrast, NooCube stands out for its clear listing of ingredients and their dosages. This openness gives you all the details you need to understand what's in it and why (29). It includes nootropic ingredients at doses that match up with those used in scientific research, offering a solid basis for its effectiveness (30). From our assessment, NooCube is one of the top nootropics out there, and it could be a good fit for you too.

When looking into nootropics, it's crucial to look for ones that are upfront about what's inside, backed by genuine research, and make believable claims. While Vitaae may seem appealing with its marketing, a closer scientific look reveals some big gaps. In comparison, NooCube offers a more dependable and scientifically backed approach (31).

1. McGlade E., et al. (2012)
2. Fioravanti M., Buckley A.E. (2006)
3. Silveri M.M. et al. (2008)
4. Secades J.J., Lorenzo J.L. (2016)
5. Malaguarnera M. (2012)
6. Jernerén F., et al. (2015)
7. Anglin R.E., et al. (2013)
8. Stahl S.M. (2008)
9. Bertone-Johnson E.R. (2009)
10. Wada H., Goto H., Hagiwara S., Yamamoto Y. (2007)
11. Ullah, I., Subhan, F., & Ayaz, M. (2019). Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology. Molecular Neurobiology, 56(7), 4925–4944.
12. Fugh-Berman, A., & Myers, A. (2004). Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research. Experimental Biology and Medicine, 229(8), 698–704.
13. Wightman, E. L., Haskell, C. F., Forster, J. S., Veasey, R. C., & Kennedy, D. O. (2012). Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation. Human Psychopharmacology: Clinical and Experimental, 27(2), 177-186.
14. Malaguarnera, M., Cammalleri, L., Gargante, M. P., Vacante, M., Colonna, V., & Motta, M. (2007). L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. The American journal of clinical nutrition, 86(6), 1738–1744.
15. Montgomery, S. A., Thal, L. J., & Amrein, R. (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology, 18(2), 61-71.
16. Levy, G. (1998). Pharmacologic target-mediated drug disposition. Clinical Pharmacology & Therapeutics, 64(3), 242–248.
17. Fasinu, P. S., Bouic, P. J., & Rosenkranz, B. (2012). An overview of the evidence and mechanisms of herb–drug interactions. Frontiers in Pharmacology, 3, 69.
18. Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in aging neuroscience, 7, 52.
19. Mujagic, Z., et al. (2014). The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Scientific reports, 4, 1-9.
20. Mozaffari, H., et al. (2020). Gastrointestinal adverse effects of short-term fish oil supplementation in healthy young men. Physiological reports, 8(11), e14455.
21. Grimstad, T., et al. (2011). Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index—a pilot study. Scandinavian journal of clinical and laboratory investigation, 71(1), 68-73.
22. Wani, M., et al. (2018). Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency. Clinical endocrinology, 89(4), 491-498.
23. Watson, P. D., et al. (1993). Effect of omega-3 fatty acids on the vascular risk factors in patients with peripheral vascular disease. Lipids, 28(4), 311-315.
24. Ueshima, H., et al. (2007). Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure. Hypertension, 50(2), 313-319.
25. Malaguarnera, M., et al. (2008). Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Archives of gerontology and geriatrics, 46(2), 181-190.
26. Goyal, R. K., et al. (2009). Asymptomatic, small-intestinal dysmotility and bacterial overgrowth in solid organ transplant recipients. Transplantation, 88(3), 352-358.
27. Hudson, S., & Tabet, N. (2003). Acetyl-L-carnitine for dementia. The Cochrane Database of Systematic Reviews, (2).
28. Molyneux, S. L., et al. (2008). Coenzyme Q10: Is there a clinical role and a case for measurement? The Clinical Biochemist Reviews, 29(2), 71.
29. Calabrese, C., et al. (2008). Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Alternative and Complementary Medicine, 14(6), 707–713.
30. White, D. J., et al. (2016). The Effects of L-Theanine on Alpha-Band Oscillatory Brain Activity During a Visuo-Spatial Attention Task. Brain Topography, 29(3), 339–354.
31. Abbiati, G., et al. (1993). Absorption, tissue distribution and excretion of radiolabelled compounds in rats after administration of [14C]-L-alpha-glycerylphosphorylcholine. European journal of drug metabolism and pharmacokinetics, 18(2), 173-180.
32. FDA. (2019). Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling.
    Ioannidis, J. P. A. (2018). The Challenge of Reforming Nutritional Epidemiologic Research. JAMA, 320(10), 969.
    Ulbricht, C., et al. (2015). An evidence-based systematic review of vitamin B12 (cobalamin) by the Natural Standard Research Collaboration. Journal of dietary supplements, 12(3), 260-294.
33. Huperzine A. (2020). In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases.
34. Sarris, J., et al. (2015). Nutrient and herbal interactions and adverse effects associated with oral supplementation for sleep. The Journal of Alternative and Complementary Medicine, 21(3), 143-155.